Healthcare provider profile · identity verified

Paul Wallace, M.D.

Internal Medicine · PHILADELPHIA, PA · NPI 1639287212

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	680	94
Amlodipine Besylate	Amlodipine Besylate	366	55
Risperidone	Risperidone	359	34
Lisinopril	Lisinopril	352	48
Metformin Hcl	Metformin Hcl	282	38
Hydrochlorothiazide	Hydrochlorothiazide	270	33
Simvastatin	Simvastatin	244	26
Metoprolol Succinate	Metoprolol Succinate	227	34
Levothyroxine Sodium	Levothyroxine Sodium	217	29
Pantoprazole Sodium	Pantoprazole Sodium	215	37
Furosemide	Furosemide	190	30
Trazodone Hcl	Trazodone Hcl	190	29
Tamsulosin Hcl	Tamsulosin Hcl	180	25
Gabapentin	Gabapentin	169	33
Benztropine Mesylate	Benztropine Mesylate	162	18
Sertraline Hcl	Sertraline Hcl	162	19
Carvedilol	Carvedilol	157	26
Farxiga	Dapagliflozin Propanediol	152	24
Ibuprofen	Ibuprofen	146	25
Albuterol Sulfate Hfa	Albuterol Sulfate	142	35
Olmesartan Medoxomil	Olmesartan Medoxomil	134	15
Eliquis	Apixaban	131	25
Metoprolol Tartrate	Metoprolol Tartrate	131	18
Mirtazapine	Mirtazapine	131	16
Omeprazole	Omeprazole	130	21
Nifedipine Er	Nifedipine	124	17
Escitalopram Oxalate	Escitalopram Oxalate	123	16
Losartan Potassium	Losartan Potassium	114	19
Famotidine	Famotidine	106	16
Olanzapine	Olanzapine	106	11
Haloperidol	Haloperidol	94	12
Quetiapine Fumarate	Quetiapine Fumarate	93	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	84	13
Divalproex Sodium	Divalproex Sodium	83	suppressed
Tramadol Hcl	Tramadol Hcl	83	19
Divalproex Sodium Er	Divalproex Sodium	82	suppressed
Aripiprazole	Aripiprazole	81	suppressed
Fluticasone Propionate	Fluticasone Propionate	81	15
Clopidogrel	Clopidogrel Bisulfate	76	17
Lovastatin	Lovastatin	75	suppressed
Potassium Chloride	Potassium Chloride	74	12
Latanoprost	Latanoprost	67	12
Fluoxetine Hcl	Fluoxetine Hcl	66	suppressed
Lorazepam	Lorazepam	66	12
Duloxetine Hcl	Duloxetine Hcl	65	13
Labetalol Hcl	Labetalol Hcl	60	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	59	suppressed
Montelukast Sodium	Montelukast Sodium	57	suppressed
Bumetanide	Bumetanide	51	11
Donepezil Hcl	Donepezil Hcl	48	11
Spironolactone	Spironolactone	48	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	48	suppressed
Allopurinol	Allopurinol	46	suppressed
Meloxicam	Meloxicam	45	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	43	suppressed
Citalopram Hbr	Citalopram Hydrobromide	42	suppressed
Jardiance	Empagliflozin	42	suppressed
Hydralazine Hcl	Hydralazine Hcl	41	suppressed
Mounjaro	Tirzepatide	41	suppressed
Trulicity	Dulaglutide	41	12
Xarelto	Rivaroxaban	41	suppressed
Lamotrigine	Lamotrigine	40	suppressed
Alendronate Sodium	Alendronate Sodium	39	suppressed
Clonazepam	Clonazepam	39	suppressed
Levetiracetam	Levetiracetam	39	suppressed
Ozempic	Semaglutide	39	suppressed
Perphenazine	Perphenazine	38	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	36	suppressed
Amantadine	Amantadine Hcl	35	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	11
Midodrine Hcl	Midodrine Hcl	35	suppressed
Nystatin	Nystatin	35	14
Valsartan	Valsartan	34	suppressed
Diclofenac Sodium	Diclofenac Sodium	33	suppressed
Pravastatin Sodium	Pravastatin Sodium	33	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	suppressed
Baclofen	Baclofen	31	suppressed
Glipizide	Glipizide	31	suppressed
Lithium Carbonate Er	Lithium Carbonate	31	suppressed
Ammonium Lactate	Ammonium Lactate	30	suppressed
Chlorthalidone	Chlorthalidone	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	30	suppressed
Prednisone	Prednisone	30	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Bupropion Hcl Sr	Bupropion Hcl	27	suppressed
Loperamide	Loperamide Hcl	27	suppressed
Tradjenta	Linagliptin	27	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Glipizide Er	Glipizide	26	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	26	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	25	21
Finasteride	Finasteride	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	23	suppressed
Doxepin Hcl	Doxepin Hcl	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Entresto	Sacubitril/Valsartan	22	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Repaglinide	Repaglinide	22	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Nitroglycerin	Nitroglycerin	21	suppressed
Clotrimazole	Clotrimazole	20	suppressed
Lidocaine	Lidocaine	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	14
Azelastine Hcl	Azelastine Hcl	19	suppressed
Diazepam	Diazepam	19	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Fluorometholone	Fluorometholone	18	suppressed
Incruse Ellipta	Umeclidinium Bromide	18	suppressed
Lactulose	Lactulose	18	suppressed
Alprazolam	Alprazolam	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Timolol Maleate	Timolol Maleate	17	suppressed
Celecoxib	Celecoxib	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Linzess	Linaclotide	16	suppressed
Mupirocin	Mupirocin	16	suppressed
Penicillin V Potassium	Penicillin V Potassium	16	suppressed
Anastrozole	Anastrozole	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Lithium Carbonate	Lithium Carbonate	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Descovy	Emtricitabine/Tenofov Alafenam	14	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	14	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	14	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Naltrexone Hcl	Naltrexone Hcl	13	suppressed
Nateglinide	Nateglinide	13	suppressed
Norethindrone	Norethindrone	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	13	suppressed
Tivicay	Dolutegravir Sodium	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Digoxin	Digoxin	12	suppressed
Methimazole	Methimazole	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Brilinta	Ticagrelor	11	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Clonidine	Clonidine	11	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	11	suppressed
Memantine Hcl Er	Memantine Hcl	11	suppressed
Nyamyc	Nystatin	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error